Crescita Therapeutics Inc.
CTX.TO News Today: Stay Updated with the Latest Crescita Therapeutics Inc. News in Real Time
Find CTX.TO news now at Meyka AI. Stay informed with the latest Crescita Therapeutics Inc. stocks updates, including price news, market analysis, and expert insights.
NSUPF Stock Bounces 4% on Apr 23 as Oversold Conditions Ease
NSUPF stock rises 4.05% to $1.90 on Apr 23, 2026. Northern Superior Resources shows oversold bounce signals amid junior mining exploration activity.
7031.T Stock Surges 35% in After-Hours Trading on April 23
7031.T stock jumps 35% to ¥771 in after-hours session. Inbound Tech Inc. gains ¥200 as multilingual CRM services drive momentum on JPX.
UTHR CEO Martine Rothblatt Sells 2,000 Shares on April 21, 2026
United Therapeutics CEO Martine Rothblatt sold 2,000 stock options at $146.03 per share on April 21, 2026, totaling $292,060.
BRCC Officer Sells 2,227 Shares: McCormick Insider Trade April 23
BRC Inc. (BRCC) officer Andrew McCormick sold 2,227 Class A shares at $0.98 on April 21, 2026. SEC Form 4 filing details.
CQD.DE Charter Communications Earnings Preview April 24
Charter Communications (CQD.DE) reports Q1 2026 earnings April 24. Analysts expect $8.55 EPS and $11.73B revenue. Stock trades at €206.75.
GNLN Insider Transactions: Directors & Officers File Initial Ownership, April 23
Three GNLN insiders file initial ownership disclosures April 23, 2026. Directors and CIO report warrant holdings totaling 1.3M shares at $0.01.
AKOM.PA Stock Surges 293% Volume on EURONEXT Pre-Market, 23 Apr 2026
AKOM.PA stock surges 293% in pre-market volume at €2.8 on EURONEXT with 7,025 shares traded.
DHI Insider Buying: 4 Executives Acquire 24,173 Shares on April 22, 2026
D.R. Horton executives acquired 24,173 shares via stock awards on April 22, 2026, including CEO, CFO, COO, and Executive Chairman.
MSS Stock April 23: Reverse Split Effective Tomorrow
Maison Solutions (MSS) executes 1-for-10 reverse stock split on April 24, 2026. Learn what this means for shareholders and trading on NASDAQ.